JPMorgan downgraded Hologic (HOLX) to Neutral from Overweight with a $78 price target after the company agreed to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Hologic Stock (HOLX) Jumps as Blackstone and TPG Take It Private in $18B Deal
- Hold Rating on Hologic Amid Acquisition by Blackstone and TPG: Limited Impact on Diagnostics Sector
- Hologic price target raised to $78 from $70 at Leerink
- Midday Fly By: GM, Coca-Cola report Q3 beats
- Hologic downgraded to Market Perform from Outperform at William Blair